The variable treatment of AI-related development spend is making like-for-like EBITDA comparisons across software and SaaS issuers more challenging, and increasing the risk that reported leverage understates cash-flow pressure.
Introduction
Documents
AI Spend Treatment Clouds Software EBITDA Comparability
6 May 2026
Contacts
Analytical
- Pinky Sharma
- Head – Corporate Credit Assessments
- pinky.sharma@arcratings.com
- Jaime Wild
- Associate Director, Corporate Ratings
- jaime.wild@arcratings.com
Business Development
- Rhonda Moore
- Business Development Director
- rhonda.moore@arcratings.com